CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-07 | Schlanger David J Executive Chairman | Sale | −5,024 | $40.63 | $204K | 82,598 |
| 2022-11-07 | Schlanger David J Executive Chairman | Sale | −50 | $41.34 | $2K | 82,548 |
| 2022-11-07 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −8,146 | 1,233,680 | ||
| 2022-11-07 | Scott Cheryl Director | Sale | −850 | $40.78 | $35K | 7,260 |
| 2022-11-07 | TPG GP A, LLC 10% owner | Sale | −750,000 | $38.75 | $29.1M | 9,250,000 |
| 2022-11-04 | Schlanger David J Executive Chairman | Exercise or conversion | +25,020 | $0.91 | $23K | 107,568 |
| 2022-11-04 | Schlanger David J Executive Chairman | Sale | −24,820 | $39.28 | $975K | 82,748 |
| 2022-11-04 | Schlanger David J Executive Chairman | Sale | −200 | $42.00 | $8K | 82,548 |
| 2022-11-04 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −25,020 | 1,241,826 | ||
| 2022-11-04 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +18,175 | $3.95 | $72K | 268,620 |
| 2022-11-04 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −18,015 | $39.29 | $708K | 250,605 |
| 2022-11-04 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −160 | $42.00 | $7K | 250,445 |
| 2022-11-04 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −4,504 | $39.29 | $177K | 163,114 |
| 2022-11-04 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −40 | $42.00 | $2K | 163,074 |
| 2022-11-04 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −18,175 | 1,381,460 | ||
| 2022-11-03 | Schlanger David J Executive Chairman | Exercise or conversion | +8,500 | $0.91 | $8K | 91,048 |
| 2022-11-03 | Schlanger David J Executive Chairman | Sale | −8,500 | $39.19 | $333K | 82,548 |
| 2022-11-03 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −8,500 | 1,266,846 | ||
| 2022-11-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +3,920 | $3.95 | $15K | 254,365 |
| 2022-11-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −3,920 | $39.19 | $154K | 250,445 |
Page 35 of 77 · 1,524 trades